Loading...
GLP‐1 suppresses glucagon secretion in human pancreatic alpha‐cells by inhibition of P/Q‐type Ca(2+) channels
Glucagon is the body's main hyperglycemic hormone, and its secretion is dysregulated in type 2 diabetes mellitus (T2DM). The incretin hormone glucagon‐like peptide‐1 (GLP‐1) is released from the gut and is used in T2DM therapy. Uniquely, it both stimulates insulin and inhibits glucagon secretio...
Na minha lista:
| Udgivet i: | Physiol Rep |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6125244/ https://ncbi.nlm.nih.gov/pubmed/30187652 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14814/phy2.13852 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|